HK$13.41
1.82%
Hong Kong, Sep 18, 03:25 pm HKT. Closed.
ISIN
KYG2524A1031
Symbol
1681

Consun Pharmaceutical Group Stock price

HK$13.17
-0.36 2.66% 1M
-3.92 22.94% 6M
-2.47 15.79% YTD
-2.77 17.38% 1Y
+8.26 168.20% 3Y
+9.54 262.53% 5Y
+8.90 208.73% 10Y
+8.59 187.31% 20Y
Hong Kong, Closing price Thu, Sep 17 2026
+0.12 0.92%
ISIN
KYG2524A1031
Symbol
1681
Industry

Is Consun Pharmaceutical Group a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.

Key metrics

Basic
Market capitalization
HK$10.7b
Enterprise Value
HK$6.4b
Net debt
positive
Cash
HK$4.6b
Shares outstanding
840.1m
Valuation (TTM | estimate)
P/E
9.0
P/S
2.7 | 2.3
EV/Sales
1.6 | 1.4
EV/FCF
4.8
P/B
2.0
Dividends
DPS
HK$0.78
Yield 1Y | 5Y
5.9% | 6.6%
Growth 1Y | 5Y
23.8% | 22.2%
Payout 1Y | 3Y
42.9% | 50.2%
Increased
4 Years
Financials (TTM | estimate)
Revenue
HK$4.0b | HK$4.6b
EBITDA
-
EBIT
HK$1.3b
Net Income
HK$1.3b
Free Cash Flow
HK$1.3b
Growth (TTM | estimate)
Revenue
15.2% | 15.9%
EBITDA
-
EBIT
17.8%
Net Income
18.4%
Free Cash Flow
16.9%
Margin
Gross
78.1%
EBITDA
-
EBIT
33.6%
Net
31.6%
Free Cash Flow
33.5%
Financial Health
Equity Ratio
70.8%
Return on Equity
23.8%
ROCE
23.1%
ROIC
103.7%
Debt/Equity
0.0
More
EPS
HK$1.5
FCF per Share
HK$1.6
Short interest
-
Employees
3k
Rev per Employee
HK$1.3m

Consun Pharmaceutical Group Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Consun Pharmaceutical Group forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Consun Pharmaceutical Group forecast:

Buy
88%
Hold
13%

Financial data from Consun Pharmaceutical Group

Dec '25
+/-
%
3,998 3,998
15% 15%
100%
- Direct Costs 878 878
3% 3%
22%
3,120 3,120
19% 19%
78%
- Selling and Administrative Expenses 1,775 1,775
18% 18%
44%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 1,344 1,344
18% 18%
34%
Net Profit 1,261 1,261
18% 18%
32%

In millions HKD.

Don't miss a Thing! We will send you all news about Consun Pharmaceutical Group directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Consun Pharmaceutical Group Ltd. is an investment holding company, which engages in the manufacturing and sales of pharmaceutical products. The firm operates its businesses through two segments. Consun Pharmaceutical segment is mainly engaged in manufacturing and sells of modern Chinese medicines and medical contrast medium. Yulin Pharmaceutical segment is mainly involved in manufacturing and sells of traditional Chinese medicines. The firm's products include kidney medicines, gynaecology and paediatrics medicines, contrast medium, orthopedics medicines, dermatologic medicines, hepatobiliary medicines and others. The firm mainly operates its businesses in the domestic market.

Head office Cayman Islands
CEO Mr. An
Employees 3,115
Website www.chinaconsun.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today